{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:00Z","timestamp":1786984260386,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Central nervous system (CNS) cancers are highly lethal and resource-intensive, imposing a substantial and uneven burden worldwide. Comparable long-term estimates of disease burden and future trends are needed to inform prevention strategies and health system planning across regions with different socioeconomic contexts. Data were obtained from the Global Burden of Disease (GBD) 2021 study covering 204 countries and territories from 1990 to 2021. We estimated incidence, prevalence, mortality, and disability-adjusted life years (DALYs) at global, regional, and national levels. Age-standardized rates were calculated using the GBD standard population to enable comparisons across populations with different age structures. Socio-demographic Index (SDI)\u2013based analyses and inequality metrics were applied to assess socioeconomic disparities in disease burden. Decomposition analysis was used to quantify the contributions of population growth, population aging, and changes in age-specific rates to DALY trends. Bayesian age\u2013period\u2013cohort (BAPC) models were employed to project future burden under the assumption that historical trends continue. In 2021, CNS cancer accounted for 0.36 million (95% UI: 0.31\u20130.41 million) new cases and 0.26 million (0.22\u20130.30 million) deaths worldwide, resulting in 8.91 million (7.61\u201310.36 million) DALYs. From 1990 to 2021, the global age-standardized incidence rate increased from 3.75 to 4.28 per 1,00,000 population, whereas the age-standardized DALY rate declined by 11.97%, indicating improved survival and disease management despite rising case numbers. Global prevalence increased from 4,34,000 in 1990 to 9,75,000 in 2021, reflecting the growing cumulative burden of individuals living with CNS cancer. Marked socioeconomic gradients were observed: high-SDI regions generally showed higher incidence rates but lower DALY rates, whereas low- and low-middle-SDI regions bore a disproportionate share of disability and premature mortality. Decomposition analysis indicated that population aging and population growth were the primary drivers of increasing DALYs, partially offset by reductions in age-specific rates. The global burden of CNS cancer is increasing, with marked socioeconomic disparities. These results are descriptive and scenario-based and should be interpreted in light of the assumptions and limitations of the GBD framework.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050073","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:02:06Z","timestamp":1786730526000},"page":"e50073","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global, regional, and national analysis of CNS cancers burden from 1990 to 2021 and forecast of disease trend over the next 25 years"],"prefix":"10.1097","volume":"105","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Oncology, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9096-6611","authenticated-orcid":false,"given":"Yinfu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second People\u2019s Hospital of Liaocheng, Liaocheng, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/neuonc\/nox091","article-title":"Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007.","volume":"19","author":"Leece","year":"2017","journal-title":"Neuro Oncol"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study.","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(17)31833-0","article-title":"GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.0.CO;2-L","article-title":"The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.","volume":"85","author":"Davis","year":"1999","journal-title":"Cancer"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study.","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","article-title":"GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40364-021-00340-6","article-title":"Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia.","volume":"9","author":"Yang","year":"2021","journal-title":"Biomark Res"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"e072385","DOI":"10.1136\/bmj-2022-072385","article-title":"Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019.","volume":"379","author":"Xie","year":"2022","journal-title":"BMJ"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"e0247120","DOI":"10.1371\/journal.pone.0247120","article-title":"A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017.","volume":"16","author":"Mohammadi","year":"2021","journal-title":"PLoS One"},{"key":"R20-20260817","first-page":"31","article-title":"Partitioning linear trends in age-adjusted rates.","volume":"11","author":"Hankey","year":"2000","journal-title":"Cancer Causes Control"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/sim.1481","article-title":"Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches.","volume":"22","author":"M\u00f8ller","year":"2003","journal-title":"Stat Med"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations.","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/neuonc\/noac213","article-title":"Disease burden, risk factors, and trends of primary central nervous system (CNS) cancer: a global study of registries data.","volume":"25","author":"Huang","year":"2023","journal-title":"Neuro Oncol"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms.","volume":"11","author":"Rubin","year":"2020","journal-title":"Biol Sex Differ"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/cam4.3823","article-title":"Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: a systematic analysis of the Global Burden of Disease Study 1990-2017.","volume":"10","author":"Azadnajafabad","year":"2021","journal-title":"Cancer Med"},{"key":"R26-20260817","first-page":"877","article-title":"GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"16","year":"2017","journal-title":"Lancet Neurol"},{"key":"R27-20260817","first-page":"376","article-title":"GBD 2016 Brain and Other CNS Cancer Collaborators. Global, regional, and national burden of brain and other CNS cancer, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"1018836","DOI":"10.3389\/fpubh.2022.1018836","article-title":"The comparative burden of brain and central nervous system cancers from 1990 to 2019 between China and the United States and predicting the future burden.","volume":"10","author":"Huang","year":"2022","journal-title":"Front Public Health"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study.","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"04144","DOI":"10.7189\/jogh.14.04144","article-title":"Impact of population ageing on cancer-related disability-adjusted life years: a global decomposition analysis.","volume":"14","author":"Zhu","year":"2024","journal-title":"J Glob Health"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1186\/s12889-023-17467-w","article-title":"The burden of brain and central nervous system cancers in Asia from 1990 to 2019 and its predicted level in the next twenty-five years: burden and prediction model of CNS cancers in Asia.","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Public Health"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(17)30818-8","article-title":"GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990\u20132015: a novel analysis from the Global Burden of Disease Study 2015.","volume":"390","year":"2017","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:06Z","timestamp":1786982466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":32,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050073","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2025-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}